Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Janney Montgomery Scott Downgrades Centerspace to Neutral

Janney Montgomery Scott analyst Robert Stevenson downgrades Centerspace (NYSE:CSR) from Buy to Neutral.

byBenzinga Newsdesk

December 14, 2022

1 minute read

Janney Montgomery Scott analyst Robert Stevenson downgrades Centerspace (NYSE:CSR) from Buy to Neutral.

Jefferies Downgrades CyrusOne to Hold, Raises Price Target to $90.5

By Benzinga Newsdesk

Today, 2:16 AM

Jefferies analyst Jonathan Petersen downgrades CyrusOne (NASDAQ:CONE) from Buy to Hold and raises the price target from $88 to $90.5.

CONE

Quest Diagnostics Updates 2021 Outlook On Surging Demand Of COVID-19 Tests

By Vandana Singh

Today, 2:16 AM

Since Quest Diagnostics Incorporated (NYSE: DGX) reported its Q2 FY21 financial results, COVID-19 molecular testing volumes were stronger than anticipated through the end of August.

DGX

electroCore Sees Q3 Revenue $1.97M Vs $2.31M Est.

By Michael Horton

Today, 2:16 AM

Financial Guidance Preliminary unaudited financial guidance for the third quarter of 2022: Revenue: The Company anticipates reporting third quarter 2022 revenue of

ECOR

F45 Training Holdings Q2 Net Loss $30.5M vs Net Income $5.9M In Same Qtr. Last Year, Adj. EBITDA $10.7M, Sales $26.80M Beat $24.99M Estimate

By Benzinga Newsdesk

Today, 2:16 AM

F45 Training Holdings (NYSE:FXLV) reported quarterly sales of $26.80 million which beat the analyst consensus estimate of $24.99 million by 7.24 percent.

FXLV

Janney Montgomery Scott Downgrades Centerspace to Neutral

Related Posts

Jefferies Downgrades CyrusOne to Hold, Raises Price Target to $90.5

Quest Diagnostics Updates 2021 Outlook On Surging Demand Of COVID-19 Tests

electroCore Sees Q3 Revenue $1.97M Vs $2.31M Est.

F45 Training Holdings Q2 Net Loss $30.5M vs Net Income $5.9M In Same Qtr. Last Year, Adj. EBITDA $10.7M, Sales $26.80M Beat $24.99M Estimate